Screening for spinal muscular atrophy

Hugo Sampaio, Bridget Wilcken and Michelle Farrar
Med J Aust 2018; 209 (4): . || doi: 10.5694/mja17.00772
Published online: 20 August 2018

Early diagnosis allows the possibility of starting treatment at a young age to achieve better outcomes

Rapid advances in technology and novel disease-modifying treatments will increase demands for early diagnosis and screening for many severe childhood conditions. This is exemplified by spinal muscular atrophy (SMA).

  • Hugo Sampaio1
  • Bridget Wilcken1,2
  • Michelle Farrar1,3

  • 1 Sydney Children's Hospital, Sydney, NSW
  • 2 Children's Hospital at Westmead, Sydney, NSW
  • 3 UNSW Sydney, Sydney, NSW


Michelle Farrar received support from the Motor Neurone Diseases Research Institute of Australia Beryl Bayley MND Postdoctoral Fellowship.

Competing interests:

Michelle Farrar has received honoraria from Biogen for consultancy.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.